tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TSE:ONC Stock Latest News

Oncolytics Biotech Appoints New Chief Business Officer to Enhance Business Strategy
Company AnnouncementsOncolytics Biotech Appoints New Chief Business Officer to Enhance Business Strategy
4d ago
ONCY
Oncolytics names Andrew Aromando as Chief Business Officer
PremiumThe Fly
Oncolytics names Andrew Aromando as Chief Business Officer
4d ago
ONCY
Oncolytics Biotech Appoints New CEO to Drive Immunotherapy Advancements
PremiumCompany Announcements
Oncolytics Biotech Appoints New CEO to Drive Immunotherapy Advancements
23d ago
ONCY
Oncolytics names Jared Kelly as CEO
PremiumThe Fly
Oncolytics names Jared Kelly as CEO
23d ago
ONCY
Oncolytics Biotech Unveils Promising Pelareorep Data at ASCO 2025
PremiumCompany Announcements
Oncolytics Biotech Unveils Promising Pelareorep Data at ASCO 2025
1M ago
ONCY
Oncolytics presents new data from Phase I/II GOBLET clinical trial
PremiumThe FlyOncolytics presents new data from Phase I/II GOBLET clinical trial
1M ago
ONCY
Promising Clinical Developments and Strategic Advancements Justify Buy Rating for Oncolytics Biotech
Premium
Ratings
Promising Clinical Developments and Strategic Advancements Justify Buy Rating for Oncolytics Biotech
1M ago
ONCY
Oncolytics downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Oncolytics downgraded to Hold from Buy at JonesResearch
2M ago
ONCY
Oncolytics Biotech’s Strategic Advances in Oncology: Promising Developments in Breast and Pancreatic Cancer Research
PremiumRatings
Oncolytics Biotech’s Strategic Advances in Oncology: Promising Developments in Breast and Pancreatic Cancer Research
2M ago
ONCY
Oncolytics Biotech’s Earnings Call: Optimism Amid Challenges
PremiumCompany Announcements
Oncolytics Biotech’s Earnings Call: Optimism Amid Challenges
2M ago
ONCY
Oncolytics Biotech Reports Q1 Results and Clinical Progress
PremiumCompany Announcements
Oncolytics Biotech Reports Q1 Results and Clinical Progress
2M ago
ONCY
Oncolytics Biotech Reports Q1 2025 Financial Results
PremiumCompany Announcements
Oncolytics Biotech Reports Q1 2025 Financial Results
2M ago
6K
ONCY
Oncolytics Biotech Reports Promising Q1 Results and Advances in Cancer Treatment
PremiumCompany AnnouncementsOncolytics Biotech Reports Promising Q1 Results and Advances in Cancer Treatment
2M ago
6K
ONCY
Oncolytics Biotech to Discuss Q1 2025 Financial Results on May 14
Premium
Company Announcements
Oncolytics Biotech to Discuss Q1 2025 Financial Results on May 14
2M ago
6K
ONCY
Oncolytics Biotech to Discuss Q1 Financial Results and Operational Highlights
Premium
Company Announcements
Oncolytics Biotech to Discuss Q1 Financial Results and Operational Highlights
2M ago
ONCY
ONCY Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ONCY Earnings this Week: How Will it Perform?
2M ago
ONCY
Oncolytics Biotech to Present Promising Pancreatic Cancer Data at ASCO 2025
PremiumCompany Announcements
Oncolytics Biotech to Present Promising Pancreatic Cancer Data at ASCO 2025
2M ago
ONCY
Oncolytics Biotech Secures $20 Million Funding for Pelareorep Development
PremiumCompany Announcements
Oncolytics Biotech Secures $20 Million Funding for Pelareorep Development
3M ago
ONCY
Oncolytics Biotech’s Pelareorep Gains Attention at Key Oncology Event
PremiumCompany Announcements
Oncolytics Biotech’s Pelareorep Gains Attention at Key Oncology Event
3M ago
ONCY
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
ABVC
CMPX
Optimistic Buy Rating for Oncolytics Biotech Driven by Promising Clinical Developments and Strategic Plans
Premium
Ratings
Optimistic Buy Rating for Oncolytics Biotech Driven by Promising Clinical Developments and Strategic Plans
4M ago
ONCY
Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating
Premium
Ratings
Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating
4M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >